These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Risk factors and outcomes of Guillain-Barré syndrome with acute myelitis. Lin JJ; Hsia SH; Wu CT; Wang HS; Lin KL; Lyu RK Pediatr Neurol; 2011 Feb; 44(2):110-6. PubMed ID: 21215910 [TBL] [Abstract][Full Text] [Related]
6. A case report of dermatomyositis mimicking myasthenia gravis. Jin ZS; Tao XR; Wang ZX Medicine (Baltimore); 2023 Dec; 102(50):e36234. PubMed ID: 38115296 [TBL] [Abstract][Full Text] [Related]
7. Newly diagnosed multiple sclerosis in a patient with ocular myasthenia gravis: A case report. Bong JB; Lee MA; Kang HG Medicine (Baltimore); 2022 Feb; 101(8):e28887. PubMed ID: 35212290 [TBL] [Abstract][Full Text] [Related]
8. Concomitant Guillain-Barré Syndrome and Acute Transverse Myelitis in an Older Adult-A Case Report. Wu CI; Wu CL; Chang KH; Huang WY Acta Neurol Taiwan; 2020 Mar; 29(1)():12-17. PubMed ID: 32285429 [TBL] [Abstract][Full Text] [Related]
9. Improving Outcome in Severe Myasthenia Gravis and Guillain-Barré Syndrome. Hawkes MA; Wijdicks EFM Semin Neurol; 2024 Jun; 44(3):263-270. PubMed ID: 38560985 [TBL] [Abstract][Full Text] [Related]
10. [High doses of immunoglobulin G in the therapy for severe forms of myasthenia gravis and Guillain-Barré syndrome]. Lavrnić D; Romić M; Kacar A; Stojanović-Rakocević V; Stević Z; Vujić A; Basta I; Marjanović I; Bogdanović G; Apostolski S Vojnosanit Pregl; 2006 Jan; 63(1):37-42. PubMed ID: 16471247 [TBL] [Abstract][Full Text] [Related]
11. NKT and NKT-like Cells in Autoimmune Neuroinflammatory Diseases-Multiple Sclerosis, Myasthenia Gravis and Guillain-Barre Syndrome. Zarobkiewicz MK; Morawska I; Michalski A; Roliński J; Bojarska-Junak A Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502425 [TBL] [Abstract][Full Text] [Related]
12. Getting Rid of Weakness in the ICU: An Updated Approach to the Acute Management of Myasthenia Gravis and Guillain-Barré Syndrome. Lizarraga AA; Lizarraga KJ; Benatar M Semin Neurol; 2016 Dec; 36(6):615-624. PubMed ID: 27907966 [TBL] [Abstract][Full Text] [Related]
13. Jaw muscle weakness: a differential indicator of neuromuscular weakness--preliminary observations. Pal S; Sanyal D Muscle Nerve; 2011 Jun; 43(6):807-11. PubMed ID: 21607965 [TBL] [Abstract][Full Text] [Related]
15. Ventilatory drive and carbon dioxide response in ventilatory failure due to myasthenia gravis and Guillain-Barré syndrome. Borel CO; Teitelbaum JS; Hanley DF Crit Care Med; 1993 Nov; 21(11):1717-26. PubMed ID: 8222689 [TBL] [Abstract][Full Text] [Related]
16. Acute Neuromuscular Disorders in the Pediatric Intensive Care Unit. Harrar DB; Darras BT; Ghosh PS J Child Neurol; 2020 Jan; 35(1):17-24. PubMed ID: 31502491 [TBL] [Abstract][Full Text] [Related]
17. [Traditional Chinese medicine insights of newly-diagnosed and young hypertension and clinical practice of Tianma Gouteng Decoction for hypertension treatment]. Meng X; Xiong XJ Zhongguo Zhong Yao Za Zhi; 2020 Jun; 45(12):2752-2759. PubMed ID: 32627447 [TBL] [Abstract][Full Text] [Related]
18. The co-occurrence of serologically proven myasthenia gravis and Miller Fisher/Guillain Barré overlap syndrome: a case report. Lau KK; Goh KJ; Lee HC; Chan YT; Tan CT J Neurol Sci; 2009 Jan; 276(1-2):187-8. PubMed ID: 18804791 [TBL] [Abstract][Full Text] [Related]
19. Increased in vitro uptake of the complement C3b in the serum of patients with Guillain-Barré syndrome, myasthenia gravis and dermatomyositis. Basta M; Illa I; Dalakas MC J Neuroimmunol; 1996 Dec; 71(1-2):227-9. PubMed ID: 8982124 [TBL] [Abstract][Full Text] [Related]
20. [Plasmapheresis in neurological diseases. Experience in 140 procedures in 47 patients]. Nogales-Gaete J; Valenzuela D; Liendo F; Vidal P; Gil G; Sáez D Rev Med Chil; 2004 Mar; 132(3):295-8. PubMed ID: 15376565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]